References
- Panidis I, Morganroth J. Mechanisms of sudden cardiac death in hospitalized patients as detected by Hotter monitoring. J Am Coll Cardiol 1983: 2: 798–805
- Bigger JT Jr. Perspectives on the current treatment of cardiac arrhythmias. Am J Cardiol 1984: 54(4): 2–7B
- Kostis JB, McCrone K, Moreyra AE, et al. Premature ventricular complexes in the absence of Identifiable heart disease. Circulation 1981: 63(6): 1351–6
- Morganroth J. Premature ventricular complexes: diagnosis and indications for therapy. JAMA 1984: 252(5): 673–6
- Morganroth J. Ambulatory electrocardiographic monitoring in the evaluation of new antiarrhythmic drugs. Circulation 1986: 73(2 Pt 2): II92–7
- Morganroth J, Anderson JL, Gentzkow GD. Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. J Am Coll Cardiol 1986: 8(3): 607–15
- Morganroth J, Michelson EL, Horowitz LN, et al. Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation 1978: 58(3): 408–14
- Jelinek MV, Lohrbauer L, Lown B. Antiarrhythmic drug therapy for sporadic ventricular ectopic arrhythmias. Circulation 1974: 49(4): 659–66
- Winkle RA. Spontaneous variation in ventricular ectopy mimics antiarrhythmic drug response. (Abstr) Circulation 1977: 56(Suppl III): III179
- Pickering TG, Goulding L, Cobern BA. Diurnal variations in ventricular ectopic beats and heart rate. Cardiovasc Med 1977: 2: 1013
- Lipaki J, Cohen L, Espinoza J, et al. Value of Hotter monitoring in assessing cardiac arrhythmias in symptomatic patients. Am J Cardiol 1976: 37(1): 102–7
- Lown B, Tykocinski M, Garfein A, et al. Sleep and ventricular premature beats. Circulation 1973: 48(4): 691–701
- Morganroth J. Risk factors for the development of proarrhythmic events. Am J Cardiol 1987: 59(11): 32–7E
- Morganroth J, Borland M, Chao G. Application of a frequency definition of ventricular proarrhythmia. Am J Cardiol 1987: 59(1): 97–9